U.S. Congress - Medical ethics 
Issue: Medical ethics
Issue's Views
- Today: 3
- Past Seven Days: 17
- All-Time: 4,762
-
H.R.6645 - Save and Strengthen Medicare Act of 2012Introduced Dec 11, 2012 (112th congress) 6 Views
To amend title XVIII of the Social Security Act to save and strengthen the Medicare program.
-
H.R.6623 - Human Cloning Prohibition Act of 2012Introduced Dec 07, 2012 (112th congress) 12 Views
To amend title 18, United States Code, to prohibit human cloning.
-
H.R.6573 - Trafficking in Organs Victims Protection ActIntroduced Oct 12, 2012 (112th congress) 12 Views
To combat trafficking in human organs, and for other purposes.
-
S.3506 - Ethical Pathway Act of 2012Introduced Aug 02, 2012 (112th congress) 5 Views
A bill to eliminate requirements to undertake duplicative clinical testing of new pharmaceutical drugs, vaccines, biological products, or medi...
-
S.2103 - District of Columbia Pain-Capable Unborn Child Protection ActIntroduced Mar 13, 2012 (112th congress) 11 Views
A bill to amend title 18, United States Code, to protect pain-capable unborn children in the District of Columbia, and for other purposes.
-
H.R.3803 - District of Columbia Pain-Capable Unborn Child Protection ActHouse Defeats Jul 31, 2012 (112th congress) 33 Views
To amend title 18, United States Code, to protect pain-capable unborn children in the District of Columbia, and for other purposes.
-
H.R.3802 - National Pro-Life Waiting Period Act of 2012Introduced Jan 23, 2012 (112th congress) 4 Views
To require an abortion provider, before performing an abortion, to wait for a period of at least 24 hours.
-
H.R.3805 - Ultrasound Informed Consent ActIntroduced Jan 23, 2012 (112th congress) 20 Views
To ensure that women seeking an abortion receive an ultrasound and the opportunity to review the ultrasound before giving informed consent to ...
-
S.1865 - Patient Access to Medical Innovation ActIntroduced Nov 15, 2011 (112th congress) 9 Views
A bill to improve patient access to medical innovation.
-
H.R.3209 - Premarket Predictability Act of 2011Introduced Oct 18, 2011 (112th congress) 10 Views
To amend the Federal Food, Drug, and Cosmetic Act to provide predictability, consistency, and transparency to the premarket review process.
